Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-R-4425 | AZD1390 CAS No.2089288-03-7 | AZD1390/CAS No.2089288-03-7 is a potent, highly selective, orally bioavailable, brain-penetrant ATM inhibitor with an IC50 of 0.78 nM in cell. | price> |
| R-R-4426 | Camonsertib CAS No.2417489-10-0 | Camonsertib (RP-3500)/CAS No.2417489-10-0 is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. Camonsertib shows 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases. Camonsertib has potent antitumor activity. | price> |
| R-C-2727 | GSK 0660 CAS:1014691-61-2 | GSK 0660 is a selective PPARβ antagonist(IC50 values are 0.155,>10 and≥10µM at PPARβ,PPARα and PPARγ respectively). | price> |
| R-R-4427 | Elimusertib hydrochloride | Elimusertib (BAY 1895344) hydrochloride is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib hydrochloride has anti-tumor activity. Elimusertib hydrochloride can be used for the research of solid tumors and lymphomas. | price> |
| R-C-2728 | Zardaverine CAS:101975-10-4 | Zardaverine is a newly developed dual-selective PDE3/4 inhibitor with IC50 values of 0.5 uM and 0.8uM respectively. | price> |
| R-R-4428 | Gartisertib CAS No.1613191-99-3 | Gartisertib (VX-803)/CAS No.1613191-99-3 is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. Gartisertib potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity. | price> |
| R-C-2729 | PF-04457845 CAS:1020315-31-4 | PF-04457845 is a highly efficacious and selective FAAH inhibitor with IC50 values is 7.2±0.63nM and 7.4±0.62nM for hFAAH and rFAAH,respectively. | price> |
| R-R-4429 | Tuvusertib CAS No.1613200-51-3 | Tuvusertib (M1774; ATR inhibitor 1)/CAS No.1613200-51-3 is a selective and orally active ATR inhibitor extracted from patent WO2015187451A1, compound I-l, with a Ki value below 1 μΜ. | price> |
| R-C-2730 | MK-8245 CAS:1030612-90-8 | MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD)with IC50 of 1 nM for human SCD1 and 3nM for both rat SCD1 and mouse SCD1,with anti-diabetic and anti-dyslipidemic efficacy.Phase 2. | price> |
| R-R-4430 | Lartesertib CAS No.2495096-26-7 | Lartesertib (M4076)/CAS No.2495096-26-7 is a potent inhibitor of serine/threonine protein kinase ATM (extracted from patent WO2022058351A1). | price> |
| R-C-2731 | ABT-046 CAS:1031336-60-3 | ABT-046 is a potent,selective,and orally efficacious acyl CoA:diacylglycerol acyltransferase 1(DGAT-1)inhibitor(IC50=8nM). | price> |
| R-R-4431 | Ro 90-7501 CAS No.293762-45-5 | Ro 90-7501/CAS No.293762-45-5 is an amyloid β42 (Aβ42) fibril assembly inhibitor that reduces Aβ42-induced cytotoxicity (EC50 of 2 μM). Ro 90-7501 inhibits ATM phosphorylation and DNA repair. RO 90-7501 selectively enhances toll-like receptor 3 (TLR3) and RIG-I-like receptor (RLR) ligand-induced IFN-β gene expression and antiviral response. Ro 90-7501 also inhibits protein phosphatase 5 (PP5) in a TPR-dependent manner. Ro 90-7501 has significant radiosensitizing effects on cervical cancer cells. | price> |
| R-C-2732 | CS@Fe3O4 nanoparticles | The product is 30nm chitosan coated Fe3O4 magnetic nanoparticles with a large number of active amino groups on the surface and a saturation magnetization of 70-80. | price> |
| R-R-4432 | (S)-Ceralasertib CAS No.1352226-87-9 | (S)-Ceralasertib ((S)-AZD6738)/CAS No.1352226-87-9 is extracted from patent WO2011154737A1, Compound II, exhibits an IC50 of 2.578 nM. (S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics. (S)-Ceralasertib is developed improving aqueous solubility and eliminates CYP3A4 time-dependent inhibition. | price> |
| R-C-2733 | MPPC | Pharmaceutical excipients,synthetic phospholipids(1-myristoyl-2-palmitoyl-sn-glycoro-3-phosphotidylcholine)were customized and synthesized in Ruixi BiotechCo.,Ltd. | price> |
| R-R-4433 | AZ32 CAS No.2288709-96-4 | AZ32/CAS No.2288709-96-4 is an orally bioavailable and blood-brain barrier-penetrating ATM inhibitor with an IC50 of <6.2 nM for ATM enzyme, and an IC50 of 0.31 μM for ATM in cell. | price> |
| R-C-2734 | A939572 CAS:1032229-33-6 | A939572 is a potent,and orally bioavailable stearoyl-CoA desaturase1(SCD1)inhibitor with IC50 values of <4nM and 37nM for mSCD1 and hSCD1,respectively. | price> |
| R-R-4434 | NU6027 CAS No.220036-08-8 | NU6027/CAS No.220036-08-8 is a potent and ATP-competitive inhibitor of both CDK1 and CDK2, with Kis of 2.5 µM and 1.3 µM, respectively. NU6027 is also a potent inhibitor of ATR and enhances hydroxyurea and cisplatin cytotoxicity in an ATR-dependent manner. | price> |
| R-C-2735 | Telotristat CAS:1033805-28-5 | Telotristat(LP-778902)is the acid form of Telotristat ethyl,and the active metabolite of LX1606(Telotristat etiprate),which is an orally bioavailable, small-molecule,tryptophan hydroxylase(TPH)inhibitor and serotonin synthesis inhibitor with potential antiserotonergic activity. | price> |
| R-R-4435 | Elimusertib-d3 | Elimusertib-d3 (BAY 1895344-d3) is the deuterium labeled Elimusertib (BAY 1895344). Elimusertib is a potent, orally active and selective ATR inhibitor and has anti-tumor activity. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


